Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coiffier

Showing results (271-280 of 289) with videos related to

Pageof 29
Sort By:
Leukemia|January 17, 2003
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patientsF Maloisel, L Benboubker, M Gardembas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the juryM A Shipp, M D Abeloff, K H Antman, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the juryM A Shipp, M D Abeloff, K H Antman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphomaS Horwitz, B Coiffier, F Foss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewG Damaj, V Verkarre, A Delmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphomaJ M Foran, A Z Rohatiner, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de MoelleM André, M Henry-Amar, J L Pico, et al.
Leukemia|July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximabJ-P Jais, C Haioun, T J Molina, et al.
Pageof 29

Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
Leukemia|January 17, 2003
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patientsF Maloisel, L Benboubker, M Gardembas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the juryM A Shipp, M D Abeloff, K H Antman, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the juryM A Shipp, M D Abeloff, K H Antman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphomaS Horwitz, B Coiffier, F Foss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewG Damaj, V Verkarre, A Delmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphomaJ M Foran, A Z Rohatiner, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de MoelleM André, M Henry-Amar, J L Pico, et al.
Leukemia|July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximabJ-P Jais, C Haioun, T J Molina, et al.
Pageof 29